CoChat

Comparison of Venlafaxine Alone Versus Venlafaxine Plus Bright Light Therapy Combination for Severe Major Depressive Disorder

Özdemir, Pınar Güzel, Boysan, Murat, Smolensky, Michael H., Selvi, Yavuz, Aydin, Adem, Yilmaz, Ekrem · 2015 · The Journal of Clinical Psychiatry

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Objective Phototherapy, ie, bright light therapy, is an effective and safe treatment of major depressive disorder (MDD). It exerts rapid mood-elevating activity, similar to antidepressant medications, most likely mediated through both monoaminergic and circadian system melatonergic mechanisms. We assessed the efficiency of bright light therapy as an adjuvant treatment to antidepressant pharmacotherapy in patients with severe MDD randomized by Hamilton Depression Rating Scale (HDRS) score to either (1) 150 mg venlafaxine hydrochloride daily at 7:00 AM or (2) 150 mg venlafaxine plus 60-minute light of 7000 lux the initial week of clinical management (venlafaxine + bright light therapy) daily at 7:00 AM. Method 50 inpatients with severe MDD at the Psychiatry Clinic of Yüzüncü Yıl University Training and Education Hospital participated. The study, which was conducted from January 2013 through June 2014, entailed patients diagnosed with severe MDD based on DSM-IV-TR for the first time. Mood states were assessed by the HDRS, Profile of Mood States (POMS), and Beck Depression Inventory (BDI) before treatment and at 1, 2, 4, and 8 weeks of treatment. Results On the basis of the HDRS score as the primary outcome variable, both strategies significantly improved depression and negative mood states already at the first treatment week (P Conclusions Both venlafaxine and venlafaxine + bright light therapy treatment strategies significantly reversed the depressive mood of patients with seve…

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.14m09376

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Cited by

See all 38

Metadata

Authors
Özdemir, P. G., Boysan, M., Smolensky, M. H., Selvi, Y., Aydin, A., & Yilmaz, E.
Affiliations
Van Yüzüncü Yıl Üniversitesi (TR)
Venue
The Journal of Clinical Psychiatry
Published
2015-05-27
Volume
76
Issue
05
Pages
e645-e654
ISSN
0160-6689 (ISSN-L)
OpenAlex
W1493162242
Cited by
38
References
2
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 7 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 2
FWCI
3.12
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Van Yüzüncü Yıl University Academic Data Management System (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords
venlafaxine, bright light therapy, phototherapy, major depressive disorder, severe depression, adjuvant therapy, antidepressant combination therapy, negative mood states, circadian rhythm, inpatient depression treatment, treatment response rate, adverse effects, sleep disorders, daytime sleepiness, anger-hostility
MeSH terms
Venlafaxine Hydrochloride, Adult, Combined Modality Therapy, Cyclohexanols, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Phototherapy, Severity of Illness Index, Treatment Outcome, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of Venlafaxine Alone Versus Venlafaxine Plus Bright Light Therapy Combination for Severe Major Depressive Disorder. https://app.cochat.ai/papers/10.4088/jcp.14m09376
The paper
Özdemir, P. G., Boysan, M., Smolensky, M. H., Selvi, Y., Aydin, A., & Yilmaz, E. (2015). Comparison of Venlafaxine Alone Versus Venlafaxine Plus Bright Light Therapy Combination for Severe Major Depressive Disorder. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.14m09376

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.